UiPath’s stock falls hard after it cuts full-year outlook
Shares of the business automation software firm UiPath Inc. fell hard today after the company lowered its forecast for the fiscal year, blaming macroeconomic uncertainty and foreign currency headwinds.
The company had just reported fairly solid second-quarter results, with a loss before certain costs such as stock compensation of just two cents per share, coming in well ahead of Wall Street’s forecast of an 11-cent-per-share loss. Revenue for the period rose 24% from a year ago, to $242.2 million, ahead of the analysts’ consensus estimate of $230.7 million. On its bottom line, UiPath reported a net loss of $120.3 million for the period, up from a $100 million net loss one year earlier.
UiPath also reported rapidly growing annual recurring revenue of $1.04 billion, up 44%, which was in line with expectations. ARR is a key metric for UiPath, since it shows how much revenue the company can expect based on subscriptions.
The company is a leader in the robotic process automation market. It sells an RPA platform that helps companies to reduce costs and operational errors by automating repetitive work. It relies on artificial intelligence models that learn how employees perform common tasks in business applications. Then it creates software robots that can replicate those workflows, thereby reducing the need to perform many of those tasks manually.
UiPath co-founder and co-Chief Executive Daniel Dines (pictured) said the company was pleased to have finally surpassed the $1 billion ARR milestone, noting that it did so in just seven years. He also cited an “unwavering commitment to innovation including the upcoming platform release, 2022.10, which we will unveil at our user conference, FORWARD 5, later this month.”
Still, Dines said nothing to soothe the fears of investors, who were clearly shocked by the much lower-than-expected forecast it offered. For the third quarter, UiPath said it expects revenue of $243 million to $245 million, with ARR of about $1.09 billion. In contrast, Wall Street had forecast $269.6 million in revenue and ARR at $1.12 billion.
UiPath’s share price, which had already fallen 3% earlier in the day, slumped by a massive 16% in after-hours trading as investors hurriedly sold off its stock.
UiPath also rolled back its fiscal 2023 forecast, saying it now expects full-year revenue of $1 billion to $1.01 billion and ARR of $1.15 billion to $1.16 billion. That’s some way below Wall Street’s consensus estimate of $1.09 billion and $1.22 billion, respectively.
“We delivered a solid second quarter fiscal 2023 despite increasing FX headwinds and macro uncertainty,” said Ashim Gupta, UiPath’s chief financial officer. “While our global footprint is an asset to the business, it exposes us to foreign exchange and macroeconomic volatility which is reflected both in our fiscal second quarter results and our fiscal third-quarter and full-year 2023 financial outlook.”
Holger Mueller of Constellation Research Inc. told SiliconANGLE that although UiPath delivered on a solid quarter, the lower guidance for the full year suggests that the once rapidly growing RPA segment is no longer quite as hot as it once was.
“The current macroeconomic environment means it’s no longer growing as it used to,” he said. “The good news is that UiPath managed to keep its costs under better control, as these were roughly similar to a year ago. That improved UiPath’s earnings per share. The question for investors now is if UiPath can generate more growth, or does it have more work to do on the cost side to get closer to profitability?”
Photo: SiliconANGLE
A message from John Furrier, co-founder of SiliconANGLE:
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide free, deep, and relevant content.
Join our community on YouTube
Join the community that includes more than 15,000 #CubeAlumni experts, including Amazon.com CEO Andy Jassy, Dell Technologies founder and CEO Michael Dell, Intel CEO Pat Gelsinger, and many more luminaries and experts.
THANK YOU